Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Total Voting Rights

31 Jan 2023 07:00

RNS Number : 2813O
Impact Healthcare REIT PLC
31 January 2023
 

31 January 2023

Impact Healthcare REIT plc

("Impact" or the "Company" or, together with its subsidiaries, the "Group")

TOTAL VOTING RIGHTS

In conformity with DTR 5.6.1R, the Company announces that, as at 31 January 2023, the Company's issued share capital consisted of 414,368,169 Ordinary Shares.

 

There are no ordinary shares held in Treasury.

 

The total number of voting rights of the Company is 414,368,169 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Andrew Cowley

Mahesh Patel

David Yaldron

 

via Maitland/amo 

Jefferies International Limited

Tom Yeadon

Andrew Morris

Ollie Nott

+44 (0) 20 7029 8000

 

 

Winterflood Securities

Darren Willis

Neil Langford

 

 

+44 (0) 20 3100 0000 

 

 

Maitland/amo (Communications Adviser)

James Benjamin

07747 113 930

impacthealth-maitland@maitland.co.uk

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

Further information on Impact Healthcare REIT is available at www.impactreit.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBDGDBXSXDGXG

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.